Shellie Keast, PharmD, PhD

MedImpact

Poster(s):

• (6) Characteristics of Medicare Part D eligible patients at risk for qualifying for the concurrent use of opioids and benzodiazepines Star Measure
  Wednesday, October 29, 2025

• (162) Preliminary associated characteristics of the top 10% of GLP-1 spenders in a self-insured health plan
  Wednesday, October 29, 2025

• (163) Characteristics associated with being adherent in patients experiencing late refills before and after the implementation of a refill reminder program
  Wednesday, October 29, 2025